Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade.

Marcus, Rebecca; Christopher, Wade; Keller, Jennifer; Nassoiy, Sean; Chang, Shu-Ching; Goldfarb, Melanie; Wolf, Ronald; Jutric, Zeljka

Marcus, Rebecca; Christopher, Wade; Keller, Jennifer; Nassoiy, Sean; Chang, Shu-Ching; Goldfarb, Melanie; Wolf, Ronald; Jutric, Zeljka.

Afiliación

Marcus R; Department of Surgical Oncology, Providence Saint John's Cancer Institute, Santa Monica, CA 90404, USA.
Christopher W; Department of Surgical Oncology, Providence Saint John's Cancer Institute, Santa Monica, CA 90404, USA.
Keller J; Department of Surgical Oncology, Providence Saint John's Cancer Institute, Santa Monica, CA 90404, USA.
Nassoiy S; Department of Surgical Oncology, Providence Saint John's Cancer Institute, Santa Monica, CA 90404, USA.
Chang SC; Medical Data Research Center, Providence Saint Joseph Health, Portland, OR 97229, USA.
Goldfarb M; Department of Surgical Oncology, Providence Saint John's Cancer Institute, Santa Monica, CA 90404, USA.
Wolf R; Division of Hepatobiliary and Pancreas Surgery, University of California Irvine, Orange, CA 92868, USA.
Jutric Z; Division of Hepatobiliary and Pancreas Surgery, University of California Irvine, Orange, CA 92868, USA.

Cancers (Basel) ; 14(17)2022 Sep 03.

Article en En | MEDLINE | ID: mdl-36077855

Palabras clave

National Cancer Database; adjuvant therapy; intrahepatic cholangiocarcinoma; neoadjuvant therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google